Latest California Healthline Stories
After Capping Insulin Copays, Colorado Sets Its Sights on EpiPens
Colorado’s proposed legislation to cap the copay for the EpiPen is part of a nationwide trend as more states try to shield patients from skyrocketing drug prices.
California dice que ya no puede costear las pruebas de covid ni las vacunas para los migrantes
El estado mantiene tres centros de recursos sanitarios —dos en el condado de San Diego y uno en el condado de Imperial— que realizan pruebas y vacunaciones contra covid y otros exámenes de salud, y han atendido a más de 300,000 migrantes desde abril de 2021.
A Bitter Battle Over the ‘Orphan Drug’ Program Leaves Patients’ Pocketbooks at Risk
Patients who depend upon special drugs to treat rare diseases are caught in the crossfire as drugmakers and the FDA battle over regulations that reward companies for developing treatments for relatively small pools of patients.
California Says It Can No Longer Afford Aid for Covid Testing, Vaccinations for Migrants
Gov. Gavin Newsom is winding down state assistance for health care services to migrants seeking asylum. He’s lobbying the Biden administration to increase aid along the state’s southern border.
Mark Cuban Has Been Taking On the Drug Industry. But Which One?
The billionaire entrepreneur and NBA team owner is making waves with his new drug company. But his generics aren’t always the lowest-priced deal.
An Arm and a Leg: She Sued a Hospital and Lost — But Felt She’d Won
A listener sued a hospital in small-claims court and lost but felt as if she’d won. Now, she wants to encourage more people to take their bills to court.
Armed With Hashtags, These Activists Made Insulin Prices a Presidential Talking Point
Twitter has been a hotbed for the burgeoning insulin access movement and activism surrounding other medical conditions. For people with diabetes, the platform has helped propel concern about insulin prices into policy. Can it continue to win with hashtags?
Watch: In Insurers’ Eyes, Not All Midwives Are Equal
The first installment of InvestigateTV and KHN’s “Costly Care” series explores one California mother’s experience struggling to get reimbursed for midwifery care and the differences between providers that may determine whether insurance covers them.
Special Delivery: Heart-Heavy Health Policy Valentines
KHN shares the cream of the crop of creative valentines about health policy submitted by readers and tweeters. Our favorite is anointed with an original illustration and bragging rights as “the one.”
Nearly $50,000 a Week for a Cancer Drug? A Man Worries About Bankrupting His Family
When Medicare stops paying for a pricey drug that prolongs life, an Ohio man considers giving up treatment to spare his family enormous debt.